Research in Germany

Press Release: November 16, 2011              

German High Tech Champions (GHTC) Award

GHTC GHTC GHTC    
 Helmut Rausch, Deputy Consul General,               Andrea Noske, Minister-Counselor,                    Daniel Sonntag, RadSpeech Business Case Presentation,   
 German Consulate                                                Embassy of the Federal Republic of Germany      Chigaco, December 2

The German High Tech Champions (GHTC) contest is aimed at technology developers that develop application oriented products or processes within the framework of their work at a university or other research institute. GHTC’s goal is to internationally increase the visibility of successful technology developers and inventors at German universities and other research institutions. The German High Tech Champions campaign is being carried out by the Fraunhofer Society and is part of the joint project “International Research Marketing” in which the Alexander von Humboldt Foundation, the
German Academic Exchange Service (DAAD), the German Research Foundation (DFG), and the Fraunhofer Society are all participating. The goal of the project is to market Germany as a research location nationally and internationally and strengthen its image in the international scientific community.  

All measures taking place within the scope of the project are components of the initiative “Advertising for Germany as a Location for Innovation and Research” under the brand “Research in Germany”, funded by the Federal Ministry of Education and Research.

Dr. Daniel Sonntag (IUI) won a German High Tech Award in 2011 for medical technology with a business case for RadSpeech, a semantic dialogue system for radiologists. The award ceremony and business case presentation will take place early December 2011 in the German Pavilion of the world’s largest convention for medical imaging, the RSNA in Chicago. There were several determining factors that led international reviewers to bestow this honor: the high marketability of mobile dialogue technology for medically relevant applications, and the maturity of DFKI technology in this segment which would enable it to exist on the international market. The marketability is confirmed by the U.S. market for mobile (medical) applications, which is quickly gaining significance. For example, in February of this year, the first iPad application for radiological patient diagnoses was approved by the FDA (U.S. Food and Drug Administration). Apple’s new Siri app is going to interest other target audiences in dialogue applications and DFKI’s dialogue technology, with real dialogue control, ties in seamlessly with the future market. With the German High Tech award, “RadSpeech” (see www.dfki.de/RadSpeech/) now has the possibility to be an international ambassador for German applied research. With this award, DFKI is, once again in 2011, a “selected place in the land of ideas.”

GHTC RadSpeech on the iPhone

What the judges had to say:

"In the field of mobile solutions, RadSpeech explores a new and promising frontier in the human-machine interaction space. While the exact use case is subject to further evolution, context based human-machine dialog functionality, possibly in combination with touchscreen devices may better enable radiologists to navigate the multimodal/multidimensional information space in which they function."
Christoph Wald, MD, PhD
Executive Vice Chairman, Department of Radiology, Lahey Clinic
Associate Professor of Radiology, Tufts University Medical School

"The German High Tech Champions presented here meet this challenge of parallel improvement and validate Germany as a top location for research and production while making an important contribution to healthcare all over the world."
Gabriel Flemming
Senior Manager Healthcare, Germany Trade and Invest GmbH

"The main areas of innovation cover add-on devices for MRI-scanners and software packages for improving data access, distribution, and communication between specialists and unifying interfaces. ... The German High Tech Champions contest has attracted a broad range of advanced medical projects that offer competitive solutions to real world problems."
Dr.-Ing. Carsten Wallenhauer
Patents and Licensing, Fraunhofer HQ

GHTC
Press Conference, RSNA 2011, Chicago